Leading global biopharmaceutical company Takeda is relocating its Berlin office – the sales headquarters for the German market – to FÜRST Berlin, the new urban quarter on Kurfürstendamm. With the new location, Takeda is strengthening its collaboration, innovative capabilities and presence within Berlin’s healthcare ecosystem. The move in is scheduled for the end of 2027.
“Berlin offers a unique environment for exchange with key stakeholders in the healthcare sector. With our new location at FÜRST Berlin on Kurfürstendamm, we are deliberately choosing proximity to relevant partners from politics, science and healthcare delivery – an important foundation for further strengthening collaboration and driving innovation. At the same time, we are creating a modern working environment that specifically supports different ways of working – from focused individual tasks to cross-functional collaboration. In this way, we combine our global perspective with a strong local presence,” says Guillaume Joachim, CFO and Managing Director of Takeda Pharma Vertrieb GmbH & Co. KG in Germany.
"With Takeda, we are deligthed to welcome an internationally renowned tenant that is an excellent fit for FÜRST as the premier business address in Berlin's City West. This letting is further proof of our quarter's strong international appeal," adds Josip Kardun, CEO of FÜRST. "With its mixed-use concept, flexible spaces and highly efficient floor plans, FÜRST offers ideal conditions for modern workplace concepts. Tenants can look forward to premium office space with LEED Platinum certification, setting new benchmarks in sustainability," adds Ryan Beckwith, Chair of FÜRST.
With Takeda on board, approximately 40 percent of the project's total space is now occupied. Further tenants at FÜRST include among others the premium apartment hotel A by Adina, premium fitness club David Lloyd, RTL, REWE and the Komödie am Kurfürstendamm theatre.
Takeda Pharmaceutical looks back on a 245-year company history. With around 2,300 employees in Germany, Takeda Germany is one of the company’s largest country organizations worldwide. In Germany, Takeda is committed to innovative healthcare solutions and relies on close collaboration with partners from research, politics and healthcare delivery. The company focuses on research and innovative therapies in the areas of gastroenterology and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.
FÜRST Berlin is an architectural landmark of Berlin's City West. Across approximately 106,000 sqm of total space, a vibrant, sustainable urban quarter is taking shape on Kurfürstendamm, featuring a unique mix of uses: around 58,000 sqm of office space, 14,200 sqm of culture and leisure, retail and a diverse range of dining options. Approximately 8,500 sqm of attractive terraces and landscaped courtyards create a high-quality environment for tenants and visitors alike.
On behalf of FÜRST, the leasing process was coordinated by Dunman Capital and CELLS, with Taurecon acting as technical and WBRE as commercial project coordinator. The transaction was facilitated by CBRE. Legal counsel for the landlord was provided by Greenberg Traurig; the tenant was advised by LAMBSDORFF.
For more information on the region's economic development or support for businesses, investors, and research institutions, please contact:
Sandra Koletzki | sandra.koletzki(at)airport-region.de
(Source: FÜRST, 06|01|2026 | “FÜRST Berlin Welcomes Takeda Pharma as New Office Tenant”)